These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29614336)

  • 1. Peripheral blood immune response-related gene analysis for evaluating the potential risk of chronic antibody-mediated rejection.
    Yamamoto T; Iwasaki K; Murotani K; Takeda A; Futamura K; Okada M; Tsujita M; Hiramitsu T; Goto N; Narumi S; Watarai Y; Morozumi K; Uchida K; Kobayashi T
    Hum Immunol; 2018 Jun; 79(6):432-438. PubMed ID: 29614336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
    Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
    Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-142-5p and miR-486-5p as biomarkers for early detection of chronic antibody-mediated rejection in kidney transplantation.
    Iwasaki K; Yamamoto T; Inanaga Y; Hiramitsu T; Miwa Y; Murotani K; Narumi S; Watarai Y; Katayama A; Uchida K; Kobayashi T
    Biomarkers; 2017 Feb; 22(1):45-54. PubMed ID: 27323802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant association between chronic antibody-mediated rejection and donor-specific antibodies against HLA-DRB rather than DQB in renal transplantation.
    Kobayashi T; Maruya E; Niwa M; Saji H; Kohara S; Katayama A; Takeda A; Watarai Y; Uchida K
    Hum Immunol; 2011 Jan; 72(1):11-7. PubMed ID: 20974206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transitional immature regulatory B cells and regulatory cytokines can discriminate chronic antibody-mediated rejection from stable graft function.
    Salehi S; Shahi A; Afzali S; Keshtkar AA; Farashi Bonab S; Soleymanian T; Ansaripour B; Amirzargar AA
    Int Immunopharmacol; 2020 Sep; 86():106750. PubMed ID: 32652501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients.
    Lee H; Min JW; Kim JI; Moon IS; Park KH; Yang CW; Chung BH; Oh EJ
    Medicine (Baltimore); 2016 Mar; 95(11):e3094. PubMed ID: 26986147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplant soluble B-cell activating factor kinetics in pediatric recipients of first kidney allograft.
    Comoli P; Quartuccio G; Cioni M; Parodi A; Nocera A; Basso S; Fontana I; Magnasco A; Sioli V; Guido I; Klersy C; Zecca M; Cardillo M; Ghiggeri GM; Ginevri F
    Transplantation; 2015 Jan; 99(1):243-9. PubMed ID: 25033258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrarenal Complement System Transcripts in Chronic Antibody-Mediated Rejection and Recurrent IgA Nephropathy in Kidney Transplantation.
    Cernoch M; Hruba P; Kollar M; Mrazova P; Stranavova L; Lodererova A; Honsova E; Viklicky O
    Front Immunol; 2018; 9():2310. PubMed ID: 30356754
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection.
    Afzali S; Salehi S; Shahi A; Esmaeili M; Farashi Bonab S; Peykari A; Bagherpour F; Ansaripour B; Soleimanian T; Pour-Reza-Gholi F; Amirzargar A
    J Immunol Res; 2021; 2021():6654992. PubMed ID: 33748289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-specific anti-HLA antibodies in pediatric renal transplant recipients with creeping creatinine: Prevalence, histological correlations, and impact on patient and graft survival.
    Monteverde ML; Chaparro A; Goldberg J; Marcos CY; Padros K; Balbarrey Z; Briones L; Rush D
    Pediatr Transplant; 2015 Nov; 19(7):684-90. PubMed ID: 26212912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation.
    Rascio F; Pontrelli P; Accetturo M; Oranger A; Gigante M; Castellano G; Gigante M; Zito A; Zaza G; Lupo A; Ranieri E; Stallone G; Gesualdo L; Grandaliano G
    J Pathol; 2015 Sep; 237(1):72-84. PubMed ID: 25925804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal monitoring of mRNA levels of regulatory T cell biomarkers by using non-invasive strategies to predict outcome in renal transplantation.
    Canossi A; Iesari S; Lai Q; Ciavatta S; Del Beato T; Panarese A; Binda B; Tessitore A; Papola F; Pisani F
    BMC Nephrol; 2022 Feb; 23(1):51. PubMed ID: 35109826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of genetic polymorphisms of macrophage inhibitory factor (MIF) and B-cell activating factor (BAFF) with the detection of donor specific antibodies in kidney allograft recipients.
    Chang Y; Shah T; Min DI
    Hum Immunol; 2017 Oct; 78(10):621-628. PubMed ID: 28624489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell activating factor, a predictor of antibody mediated rejection in kidney transplantation recipients.
    Pongpirul W; Chancharoenthana W; Pongpirul K; Leelahavanichkul A; Kittikowit W; Jutivorakool K; Nonthasoot B; Avihingsanon Y; Eiam-Ong S; Praditpornsilpa K; Townamchai N
    Nephrology (Carlton); 2018 Feb; 23(2):169-174. PubMed ID: 27888573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection.
    Danger R; Paul C; Giral M; Lavault A; Foucher Y; Degauque N; Pallier A; Durand M; Castagnet S; Duong Van Huyen JP; Delahousse M; Renaudin K; Soulillou JP; Brouard S
    PLoS One; 2013; 8(4):e60702. PubMed ID: 23577151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation.
    Huang Y; Ramon D; Luan FL; Sung R; Samaniego M
    Clin Transpl; 2012; ():247-56. PubMed ID: 23721029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies.
    Ixtlapale-Carmona X; Arvizu A; De-Santiago A; González-Tableros N; López M; Castelán N; Marino LA; Uribe-Uribe NO; Contreras AG; Vilatobá M; Morales-Buenrostro LE; Alberú J
    Transpl Immunol; 2018 Feb; 46():8-13. PubMed ID: 28974434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialylation of antibodies in kidney recipients with de novo donor specific antibody, with or without antibody mediated rejection.
    Malard-Castagnet S; Dugast E; Degauque N; Pallier A; Soulillou JP; Cesbron A; Giral M; Harb J; Brouard S
    Hum Immunol; 2016 Nov; 77(11):1076-1083. PubMed ID: 26546874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic AMR in Liver Transplant: Validation of the 1-Year cAMR Score's Ability to Determine Long-term Outcome.
    O'Leary JG; Smith C; Cai J; Hart B; Jennings LW; Everly M; Klintmalm GB; Demetris AJ
    Transplantation; 2017 Sep; 101(9):2062-2070. PubMed ID: 28452922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in CTLA-4 predict de novo donor specific antibody formation after kidney transplantation.
    Ono K; Ide K; Kashihara M; Yamane H; Akimoto S; Tanimine N; Tahara H; Ohira M; Tanaka Y; Ohdan H
    Hum Immunol; 2022 Jun; 83(6):494-498. PubMed ID: 35365357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.